Paper320661
Control of influenza and poliomyelitis with killed virus vaccines.
Salk J and 1 other. Science, 1977. Cited by 144 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Control of influenza and poliomyelitis with killed virus vaccines. Papers, record 320661. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/320661
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Influenza Vaccines | Major topic |
| Influenza, Human | Major topic |
| Poliomyelitis | Major topic |
| Poliovirus Vaccine, Inactivated | Major topic |
| Adjuvants, Immunologic | |
| Antibodies, Viral | |
| Antigens, Viral | |
| Europe | |
| Humans | |
| Mineral Oil | |
| Orthomyxoviridae | |
| Time Factors | |
| United States | |
| Vaccination | |
| Vaccines, Attenuated |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,905,532 | Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus. | Virol Sin | 2026 | https://conductscience.org/library/papers/41905532 | PubMed |
| 39,794,927 | Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/39794927 | PubMed |
| 38,250,843 | Nanoparticles and Antiviral Vaccines. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38250843 | PubMed |
| 37,008,622 | Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination. | J Clin Transl Sci | 2023 | https://conductscience.org/library/papers/37008622 | PubMed |
| 34,787,781 | Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology. | Bull Exp Biol Med | 2021 | https://conductscience.org/library/papers/34787781 | PubMed |
| 32,287,579 | Chapter 4 Picornavirus infections. | Perspect Med Virol | 1985 | https://conductscience.org/library/papers/32287579 | PubMed |
| 30,637,122 | The PathLink Acquired Gestational Tissue Bank: Feasibility of Project PLACENTA. | J Reprod Biotechnol Fertil | 2018 | https://conductscience.org/library/papers/30637122 | PubMed |
| 28,025,504 | Reverse Genetics Approaches for the Development of Influenza Vaccines. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/28025504 | PubMed |
| 28,004,787 | Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum. | Sci Rep | 2016 | https://conductscience.org/library/papers/28004787 | PubMed |
| 23,960,760 | Vaccine adjuvants - Current status and prospects on controlled release adjuvancity. | Saudi Pharm J | 2011 | https://conductscience.org/library/papers/23960760 | PubMed |
| 23,824,369 | Traditional and new influenza vaccines. | Clin Microbiol Rev | 2013 | https://conductscience.org/library/papers/23824369 | PubMed |
| 21,206,484 | Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs. | Mol Ther | 2011 | https://conductscience.org/library/papers/21206484 | PubMed |
| 19,931,408 | Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. | J Autoimmun | 2010 | https://conductscience.org/library/papers/19931408 | PubMed |
| 19,135,117 | A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. | Vaccine | 2009 | https://conductscience.org/library/papers/19135117 | PubMed |
| 17,917,038 | Immunity and protection, the unfolding of a tale. | Immunol Res | 2007 | https://conductscience.org/library/papers/17917038 | PubMed |
| 16,792,682 | Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity. | Clin Exp Immunol | 2006 | https://conductscience.org/library/papers/16792682 | PubMed |
| 15,951,823 | Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. | Nat Med | 2005 | https://conductscience.org/library/papers/15951823 | PubMed |
| 12,059,113 | The development and use of vaccine adjuvants. | Mol Biotechnol | 2002 | https://conductscience.org/library/papers/12059113 | PubMed |
| 11,101,561 | Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications. | J Clin Microbiol | 2000 | https://conductscience.org/library/papers/11101561 | PubMed |
| 9,311,873 | Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice. | J Virol | 1997 | https://conductscience.org/library/papers/9311873 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/320661
GET https://conductscience.org/api/papers/v1/320661/cited_by?page=2